Inventor
HUANG-TSU CHEN
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07KPeptides29%
C12NMicroorganisms or enzymes6%
C12YEnzymes6%
PatentTitleYear
12,054,561Anti-angiogenesis fusion protein and uses thereof202411,518,984Protein inhibitors to complement and VEGF pathways and methods of use thereof202211,518,819Anti-angiogenesis fusion protein and uses thereof202211,390,677Human anti-CD47 antibodies and uses thereof202211,299,531Fusion protein comprising a ligand binding domain of VEGF and PDGF2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to TRICAN BIOTECHNOLOGY CO LTD (3)· patent assignee history
2022Patents assigned to AP BIOSCIENCES INC (2)· patent assignee history
2022Patents assigned to ALLGENESIS BIOTHERAPEUTICS INC (1)· patent assignee history
2022Patents assigned to INNOVENT BIOLOGICS INC (1)· patent assignee history
2022Patents assigned to INNOVENT BIOLOGIS INC (1)· patent assignee history
2022–2024Based in US· patent location history
2022Based in TW· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| TRICAN BIOTECHNOLOGY CO LTD | 3 | 2022–2024 |
| AP BIOSCIENCES INC | 2 | 2022 |
| ALLGENESIS BIOTHERAPEUTICS INC | 1 | 2022 |
| INNOVENT BIOLOGICS INC | 1 | 2022 |
| INNOVENT BIOLOGIS INC | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 4 | 2022–2024 |
| TW | 1 | 2022 |